The new era of immunotherapy for breast cancer: challenges and coping strategies of CAR-T cell therapy
Breast cancer remains the most prevalent malignant tumor among women globally, with persistently high incidence and mortality rates. Despite the diversity of existing treatment modalities, systemic therapies for advanced, metastatic, and triple-negativ…